nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Didanosine—PNP—osteoporosis	0.0494	0.796	CrCbGaD
Entecavir—Cladribine—PNP—osteoporosis	0.0127	0.204	CrCbGaD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00363	0.00387	CcSEcCtD
Entecavir—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00361	0.00385	CcSEcCtD
Entecavir—Haematuria—Zoledronate—osteoporosis	0.00359	0.00383	CcSEcCtD
Entecavir—Renal failure—Conjugated Estrogens—osteoporosis	0.00356	0.0038	CcSEcCtD
Entecavir—Dyspepsia—Etidronic acid—osteoporosis	0.00356	0.0038	CcSEcCtD
Entecavir—Alopecia—Ethinyl Estradiol—osteoporosis	0.00353	0.00376	CcSEcCtD
Entecavir—Immune system disorder—Risedronate—osteoporosis	0.00352	0.00375	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00351	0.00374	CcSEcCtD
Entecavir—Anaphylactic shock—Estropipate—osteoporosis	0.0035	0.00373	CcSEcCtD
Entecavir—Mental disorder—Ethinyl Estradiol—osteoporosis	0.0035	0.00373	CcSEcCtD
Entecavir—Infection—Estropipate—osteoporosis	0.00348	0.00371	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00348	0.00371	CcSEcCtD
Entecavir—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00348	0.00371	CcSEcCtD
Entecavir—Abdominal pain upper—Estradiol—osteoporosis	0.00344	0.00367	CcSEcCtD
Entecavir—Nervous system disorder—Estropipate—osteoporosis	0.00343	0.00366	CcSEcCtD
Entecavir—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00343	0.00366	CcSEcCtD
Entecavir—Infection—Alendronate—osteoporosis	0.00342	0.00365	CcSEcCtD
Entecavir—Mental disorder—Risedronate—osteoporosis	0.00341	0.00364	CcSEcCtD
Entecavir—Skin disorder—Estropipate—osteoporosis	0.0034	0.00362	CcSEcCtD
Entecavir—Malnutrition—Risedronate—osteoporosis	0.00339	0.00361	CcSEcCtD
Entecavir—Infection—Raloxifene—osteoporosis	0.00337	0.00359	CcSEcCtD
Entecavir—Anaphylactic shock—Ibandronate—osteoporosis	0.00336	0.00358	CcSEcCtD
Entecavir—Immune system disorder—Pamidronate—osteoporosis	0.00334	0.00356	CcSEcCtD
Entecavir—Infection—Ibandronate—osteoporosis	0.00333	0.00356	CcSEcCtD
Entecavir—Oedema peripheral—Zoledronate—osteoporosis	0.00333	0.00355	CcSEcCtD
Entecavir—Nervous system disorder—Raloxifene—osteoporosis	0.00332	0.00354	CcSEcCtD
Entecavir—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00331	0.00353	CcSEcCtD
Entecavir—Skin disorder—Raloxifene—osteoporosis	0.00329	0.00351	CcSEcCtD
Entecavir—Nervous system disorder—Ibandronate—osteoporosis	0.00329	0.00351	CcSEcCtD
Entecavir—Anaphylactic shock—Calcitriol—osteoporosis	0.00329	0.0035	CcSEcCtD
Entecavir—Alopecia—Pamidronate—osteoporosis	0.00327	0.00349	CcSEcCtD
Entecavir—Skin disorder—Ibandronate—osteoporosis	0.00326	0.00348	CcSEcCtD
Entecavir—Nausea—Ergocalciferol—osteoporosis	0.00323	0.00345	CcSEcCtD
Entecavir—Malnutrition—Pamidronate—osteoporosis	0.00322	0.00344	CcSEcCtD
Entecavir—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00321	0.00342	CcSEcCtD
Entecavir—Abdominal pain—Etidronic acid—osteoporosis	0.0032	0.00341	CcSEcCtD
Entecavir—Skin disorder—Calcitriol—osteoporosis	0.00319	0.0034	CcSEcCtD
Entecavir—Pancreatitis—Estradiol—osteoporosis	0.00319	0.0034	CcSEcCtD
Entecavir—Insomnia—Estropipate—osteoporosis	0.00317	0.00338	CcSEcCtD
Entecavir—Somnolence—Estropipate—osteoporosis	0.00311	0.00332	CcSEcCtD
Entecavir—Dyspepsia—Estropipate—osteoporosis	0.00308	0.00328	CcSEcCtD
Entecavir—Insomnia—Raloxifene—osteoporosis	0.00307	0.00327	CcSEcCtD
Entecavir—Immune system disorder—Zoledronate—osteoporosis	0.00305	0.00326	CcSEcCtD
Entecavir—Insomnia—Ibandronate—osteoporosis	0.00304	0.00324	CcSEcCtD
Entecavir—Dyspepsia—Alendronate—osteoporosis	0.00303	0.00324	CcSEcCtD
Entecavir—Upper respiratory tract infection—Estradiol—osteoporosis	0.00302	0.00323	CcSEcCtD
Entecavir—Gastrointestinal disorder—Estropipate—osteoporosis	0.00302	0.00322	CcSEcCtD
Entecavir—Fatigue—Estropipate—osteoporosis	0.00302	0.00322	CcSEcCtD
Entecavir—Alopecia—Zoledronate—osteoporosis	0.00299	0.00319	CcSEcCtD
Entecavir—Dyspepsia—Raloxifene—osteoporosis	0.00298	0.00318	CcSEcCtD
Entecavir—Insomnia—Calcitriol—osteoporosis	0.00297	0.00317	CcSEcCtD
Entecavir—Mental disorder—Zoledronate—osteoporosis	0.00296	0.00316	CcSEcCtD
Entecavir—Dyspepsia—Ibandronate—osteoporosis	0.00295	0.00315	CcSEcCtD
Entecavir—Malnutrition—Zoledronate—osteoporosis	0.00294	0.00314	CcSEcCtD
Entecavir—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00294	0.00313	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00294	0.00313	CcSEcCtD
Entecavir—Hyperglycaemia—Estradiol—osteoporosis	0.00294	0.00313	CcSEcCtD
Entecavir—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00293	0.00312	CcSEcCtD
Entecavir—Somnolence—Calcitriol—osteoporosis	0.00292	0.00311	CcSEcCtD
Entecavir—Gastrointestinal disorder—Ibandronate—osteoporosis	0.0029	0.00309	CcSEcCtD
Entecavir—Fatigue—Ibandronate—osteoporosis	0.00289	0.00309	CcSEcCtD
Entecavir—Leukopenia—Pamidronate—osteoporosis	0.00288	0.00307	CcSEcCtD
Entecavir—Alopecia—Conjugated Estrogens—osteoporosis	0.00288	0.00307	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00287	0.00306	CcSEcCtD
Entecavir—Gastrointestinal pain—Estropipate—osteoporosis	0.00286	0.00305	CcSEcCtD
Entecavir—Mental disorder—Conjugated Estrogens—osteoporosis	0.00285	0.00304	CcSEcCtD
Entecavir—Malnutrition—Conjugated Estrogens—osteoporosis	0.00283	0.00302	CcSEcCtD
Entecavir—Gastrointestinal pain—Alendronate—osteoporosis	0.00282	0.00301	CcSEcCtD
Entecavir—Infection—Ethinyl Estradiol—osteoporosis	0.00282	0.003	CcSEcCtD
Entecavir—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00278	0.00297	CcSEcCtD
Entecavir—Gastrointestinal pain—Raloxifene—osteoporosis	0.00277	0.00296	CcSEcCtD
Entecavir—Diarrhoea—Etidronic acid—osteoporosis	0.00277	0.00295	CcSEcCtD
Entecavir—Haematuria—Estradiol—osteoporosis	0.00277	0.00295	CcSEcCtD
Entecavir—Abdominal pain—Estropipate—osteoporosis	0.00277	0.00295	CcSEcCtD
Entecavir—Body temperature increased—Estropipate—osteoporosis	0.00277	0.00295	CcSEcCtD
Entecavir—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00276	0.00294	CcSEcCtD
Entecavir—Infection—Risedronate—osteoporosis	0.00275	0.00293	CcSEcCtD
Entecavir—Hepatobiliary disease—Estradiol—osteoporosis	0.00274	0.00293	CcSEcCtD
Entecavir—Gastrointestinal pain—Ibandronate—osteoporosis	0.00274	0.00293	CcSEcCtD
Entecavir—Abdominal pain—Alendronate—osteoporosis	0.00273	0.00291	CcSEcCtD
Entecavir—Body temperature increased—Alendronate—osteoporosis	0.00273	0.00291	CcSEcCtD
Entecavir—Nervous system disorder—Risedronate—osteoporosis	0.00271	0.00289	CcSEcCtD
Entecavir—Skin disorder—Risedronate—osteoporosis	0.00269	0.00286	CcSEcCtD
Entecavir—Gastrointestinal pain—Calcitriol—osteoporosis	0.00269	0.00286	CcSEcCtD
Entecavir—Body temperature increased—Raloxifene—osteoporosis	0.00268	0.00286	CcSEcCtD
Entecavir—Abdominal pain—Raloxifene—osteoporosis	0.00268	0.00286	CcSEcCtD
Entecavir—Body temperature increased—Ibandronate—osteoporosis	0.00265	0.00283	CcSEcCtD
Entecavir—Abdominal pain—Ibandronate—osteoporosis	0.00265	0.00283	CcSEcCtD
Entecavir—Leukopenia—Zoledronate—osteoporosis	0.00263	0.00281	CcSEcCtD
Entecavir—Anaphylactic shock—Pamidronate—osteoporosis	0.00263	0.0028	CcSEcCtD
Entecavir—Infection—Pamidronate—osteoporosis	0.00261	0.00279	CcSEcCtD
Entecavir—Hepatitis—Estradiol—osteoporosis	0.00261	0.00278	CcSEcCtD
Entecavir—Abdominal pain—Calcitriol—osteoporosis	0.0026	0.00277	CcSEcCtD
Entecavir—Body temperature increased—Calcitriol—osteoporosis	0.0026	0.00277	CcSEcCtD
Entecavir—Nervous system disorder—Pamidronate—osteoporosis	0.00258	0.00275	CcSEcCtD
Entecavir—Vomiting—Etidronic acid—osteoporosis	0.00257	0.00274	CcSEcCtD
Entecavir—Oedema peripheral—Estradiol—osteoporosis	0.00257	0.00274	CcSEcCtD
Entecavir—Rash—Etidronic acid—osteoporosis	0.00255	0.00272	CcSEcCtD
Entecavir—Dermatitis—Etidronic acid—osteoporosis	0.00255	0.00272	CcSEcCtD
Entecavir—Headache—Etidronic acid—osteoporosis	0.00253	0.0027	CcSEcCtD
Entecavir—Asthenia—Estropipate—osteoporosis	0.00251	0.00268	CcSEcCtD
Entecavir—Insomnia—Risedronate—osteoporosis	0.0025	0.00267	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00249	0.00265	CcSEcCtD
Entecavir—Asthenia—Alendronate—osteoporosis	0.00247	0.00264	CcSEcCtD
Entecavir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00245	0.00261	CcSEcCtD
Entecavir—Fatigue—Ethinyl Estradiol—osteoporosis	0.00245	0.00261	CcSEcCtD
Entecavir—Dyspepsia—Risedronate—osteoporosis	0.00243	0.0026	CcSEcCtD
Entecavir—Asthenia—Ibandronate—osteoporosis	0.00241	0.00257	CcSEcCtD
Entecavir—Nausea—Etidronic acid—osteoporosis	0.0024	0.00256	CcSEcCtD
Entecavir—Anaphylactic shock—Zoledronate—osteoporosis	0.0024	0.00256	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.0024	0.00255	CcSEcCtD
Entecavir—Diarrhoea—Estropipate—osteoporosis	0.00239	0.00255	CcSEcCtD
Entecavir—Gastrointestinal disorder—Risedronate—osteoporosis	0.00239	0.00255	CcSEcCtD
Entecavir—Infection—Zoledronate—osteoporosis	0.00239	0.00254	CcSEcCtD
Entecavir—Fatigue—Risedronate—osteoporosis	0.00238	0.00254	CcSEcCtD
Entecavir—Insomnia—Pamidronate—osteoporosis	0.00238	0.00254	CcSEcCtD
Entecavir—Diarrhoea—Alendronate—osteoporosis	0.00236	0.00251	CcSEcCtD
Entecavir—Asthenia—Calcitriol—osteoporosis	0.00236	0.00251	CcSEcCtD
Entecavir—Nervous system disorder—Zoledronate—osteoporosis	0.00236	0.00251	CcSEcCtD
Entecavir—Immune system disorder—Estradiol—osteoporosis	0.00235	0.00251	CcSEcCtD
Entecavir—Somnolence—Pamidronate—osteoporosis	0.00234	0.00249	CcSEcCtD
Entecavir—Skin disorder—Zoledronate—osteoporosis	0.00233	0.00249	CcSEcCtD
Entecavir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00232	0.00247	CcSEcCtD
Entecavir—Diarrhoea—Raloxifene—osteoporosis	0.00232	0.00247	CcSEcCtD
Entecavir—Dyspepsia—Pamidronate—osteoporosis	0.00231	0.00247	CcSEcCtD
Entecavir—Dizziness—Estropipate—osteoporosis	0.00231	0.00247	CcSEcCtD
Entecavir—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00231	0.00247	CcSEcCtD
Entecavir—Alopecia—Estradiol—osteoporosis	0.0023	0.00245	CcSEcCtD
Entecavir—Infection—Conjugated Estrogens—osteoporosis	0.0023	0.00245	CcSEcCtD
Entecavir—Diarrhoea—Ibandronate—osteoporosis	0.0023	0.00245	CcSEcCtD
Entecavir—Mental disorder—Estradiol—osteoporosis	0.00228	0.00243	CcSEcCtD
Entecavir—Dizziness—Alendronate—osteoporosis	0.00228	0.00243	CcSEcCtD
Entecavir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00227	0.00242	CcSEcCtD
Entecavir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00227	0.00242	CcSEcCtD
Entecavir—Malnutrition—Estradiol—osteoporosis	0.00227	0.00242	CcSEcCtD
Entecavir—Fatigue—Pamidronate—osteoporosis	0.00227	0.00242	CcSEcCtD
Entecavir—Gastrointestinal pain—Risedronate—osteoporosis	0.00226	0.00241	CcSEcCtD
Entecavir—Diarrhoea—Calcitriol—osteoporosis	0.00225	0.0024	CcSEcCtD
Entecavir—Skin disorder—Conjugated Estrogens—osteoporosis	0.00225	0.0024	CcSEcCtD
Entecavir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00224	0.00239	CcSEcCtD
Entecavir—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00224	0.00239	CcSEcCtD
Entecavir—Dizziness—Raloxifene—osteoporosis	0.00224	0.00239	CcSEcCtD
Entecavir—Vomiting—Estropipate—osteoporosis	0.00223	0.00237	CcSEcCtD
Entecavir—Dizziness—Ibandronate—osteoporosis	0.00222	0.00237	CcSEcCtD
Entecavir—Rash—Estropipate—osteoporosis	0.00221	0.00235	CcSEcCtD
Entecavir—Dermatitis—Estropipate—osteoporosis	0.0022	0.00235	CcSEcCtD
Entecavir—Headache—Estropipate—osteoporosis	0.00219	0.00234	CcSEcCtD
Entecavir—Vomiting—Alendronate—osteoporosis	0.00219	0.00234	CcSEcCtD
Entecavir—Body temperature increased—Risedronate—osteoporosis	0.00219	0.00233	CcSEcCtD
Entecavir—Abdominal pain—Risedronate—osteoporosis	0.00219	0.00233	CcSEcCtD
Entecavir—Rash—Alendronate—osteoporosis	0.00217	0.00232	CcSEcCtD
Entecavir—Insomnia—Zoledronate—osteoporosis	0.00217	0.00232	CcSEcCtD
Entecavir—Dermatitis—Alendronate—osteoporosis	0.00217	0.00232	CcSEcCtD
Entecavir—Headache—Alendronate—osteoporosis	0.00216	0.0023	CcSEcCtD
Entecavir—Vomiting—Raloxifene—osteoporosis	0.00216	0.0023	CcSEcCtD
Entecavir—Gastrointestinal pain—Pamidronate—osteoporosis	0.00215	0.00229	CcSEcCtD
Entecavir—Rash—Raloxifene—osteoporosis	0.00214	0.00228	CcSEcCtD
Entecavir—Dermatitis—Raloxifene—osteoporosis	0.00214	0.00228	CcSEcCtD
Entecavir—Somnolence—Zoledronate—osteoporosis	0.00214	0.00228	CcSEcCtD
Entecavir—Vomiting—Ibandronate—osteoporosis	0.00213	0.00228	CcSEcCtD
Entecavir—Headache—Raloxifene—osteoporosis	0.00212	0.00226	CcSEcCtD
Entecavir—Rash—Ibandronate—osteoporosis	0.00212	0.00226	CcSEcCtD
Entecavir—Dermatitis—Ibandronate—osteoporosis	0.00211	0.00225	CcSEcCtD
Entecavir—Dyspepsia—Zoledronate—osteoporosis	0.00211	0.00225	CcSEcCtD
Entecavir—Headache—Ibandronate—osteoporosis	0.0021	0.00224	CcSEcCtD
Entecavir—Insomnia—Conjugated Estrogens—osteoporosis	0.00209	0.00223	CcSEcCtD
Entecavir—Vomiting—Calcitriol—osteoporosis	0.00209	0.00223	CcSEcCtD
Entecavir—Nausea—Estropipate—osteoporosis	0.00208	0.00222	CcSEcCtD
Entecavir—Abdominal pain—Pamidronate—osteoporosis	0.00208	0.00222	CcSEcCtD
Entecavir—Body temperature increased—Pamidronate—osteoporosis	0.00208	0.00222	CcSEcCtD
Entecavir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00207	0.00221	CcSEcCtD
Entecavir—Rash—Calcitriol—osteoporosis	0.00207	0.00221	CcSEcCtD
Entecavir—Fatigue—Zoledronate—osteoporosis	0.00207	0.00221	CcSEcCtD
Entecavir—Dermatitis—Calcitriol—osteoporosis	0.00207	0.00221	CcSEcCtD
Entecavir—Headache—Calcitriol—osteoporosis	0.00206	0.00219	CcSEcCtD
Entecavir—Somnolence—Conjugated Estrogens—osteoporosis	0.00206	0.00219	CcSEcCtD
Entecavir—Nausea—Alendronate—osteoporosis	0.00205	0.00218	CcSEcCtD
Entecavir—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00204	0.00217	CcSEcCtD
Entecavir—Asthenia—Ethinyl Estradiol—osteoporosis	0.00204	0.00217	CcSEcCtD
Entecavir—Nausea—Raloxifene—osteoporosis	0.00201	0.00215	CcSEcCtD
Entecavir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.002	0.00213	CcSEcCtD
Entecavir—Fatigue—Conjugated Estrogens—osteoporosis	0.00199	0.00213	CcSEcCtD
Entecavir—Nausea—Ibandronate—osteoporosis	0.00199	0.00213	CcSEcCtD
Entecavir—Asthenia—Risedronate—osteoporosis	0.00198	0.00212	CcSEcCtD
Entecavir—Gastrointestinal pain—Zoledronate—osteoporosis	0.00196	0.00209	CcSEcCtD
Entecavir—Nausea—Calcitriol—osteoporosis	0.00195	0.00208	CcSEcCtD
Entecavir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00194	0.00207	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00192	0.00204	CcSEcCtD
Entecavir—Abdominal pain—Zoledronate—osteoporosis	0.0019	0.00202	CcSEcCtD
Entecavir—Body temperature increased—Zoledronate—osteoporosis	0.0019	0.00202	CcSEcCtD
Entecavir—Diarrhoea—Risedronate—osteoporosis	0.00189	0.00202	CcSEcCtD
Entecavir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00189	0.00202	CcSEcCtD
Entecavir—Asthenia—Pamidronate—osteoporosis	0.00189	0.00201	CcSEcCtD
Entecavir—Dizziness—Ethinyl Estradiol—osteoporosis	0.00188	0.002	CcSEcCtD
Entecavir—Anaphylactic shock—Estradiol—osteoporosis	0.00185	0.00197	CcSEcCtD
Entecavir—Infection—Estradiol—osteoporosis	0.00184	0.00196	CcSEcCtD
Entecavir—Dizziness—Risedronate—osteoporosis	0.00183	0.00195	CcSEcCtD
Entecavir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00183	0.00195	CcSEcCtD
Entecavir—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00183	0.00195	CcSEcCtD
Entecavir—Nervous system disorder—Estradiol—osteoporosis	0.00182	0.00194	CcSEcCtD
Entecavir—Vomiting—Ethinyl Estradiol—osteoporosis	0.0018	0.00192	CcSEcCtD
Entecavir—Diarrhoea—Pamidronate—osteoporosis	0.0018	0.00192	CcSEcCtD
Entecavir—Skin disorder—Estradiol—osteoporosis	0.0018	0.00192	CcSEcCtD
Entecavir—Rash—Ethinyl Estradiol—osteoporosis	0.00179	0.00191	CcSEcCtD
Entecavir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00179	0.00191	CcSEcCtD
Entecavir—Headache—Ethinyl Estradiol—osteoporosis	0.00178	0.00189	CcSEcCtD
Entecavir—Vomiting—Risedronate—osteoporosis	0.00176	0.00188	CcSEcCtD
Entecavir—Rash—Risedronate—osteoporosis	0.00174	0.00186	CcSEcCtD
Entecavir—Dermatitis—Risedronate—osteoporosis	0.00174	0.00186	CcSEcCtD
Entecavir—Dizziness—Pamidronate—osteoporosis	0.00174	0.00185	CcSEcCtD
Entecavir—Headache—Risedronate—osteoporosis	0.00173	0.00185	CcSEcCtD
Entecavir—Asthenia—Zoledronate—osteoporosis	0.00172	0.00184	CcSEcCtD
Entecavir—Nausea—Ethinyl Estradiol—osteoporosis	0.00169	0.0018	CcSEcCtD
Entecavir—Insomnia—Estradiol—osteoporosis	0.00167	0.00178	CcSEcCtD
Entecavir—Vomiting—Pamidronate—osteoporosis	0.00167	0.00178	CcSEcCtD
Entecavir—Asthenia—Conjugated Estrogens—osteoporosis	0.00166	0.00177	CcSEcCtD
Entecavir—Rash—Pamidronate—osteoporosis	0.00166	0.00177	CcSEcCtD
Entecavir—Dermatitis—Pamidronate—osteoporosis	0.00166	0.00177	CcSEcCtD
Entecavir—Headache—Pamidronate—osteoporosis	0.00165	0.00176	CcSEcCtD
Entecavir—Somnolence—Estradiol—osteoporosis	0.00165	0.00175	CcSEcCtD
Entecavir—Diarrhoea—Zoledronate—osteoporosis	0.00164	0.00175	CcSEcCtD
Entecavir—Nausea—Risedronate—osteoporosis	0.00164	0.00175	CcSEcCtD
Entecavir—Dyspepsia—Estradiol—osteoporosis	0.00163	0.00174	CcSEcCtD
Entecavir—Gastrointestinal disorder—Estradiol—osteoporosis	0.0016	0.0017	CcSEcCtD
Entecavir—Fatigue—Estradiol—osteoporosis	0.0016	0.0017	CcSEcCtD
Entecavir—Dizziness—Zoledronate—osteoporosis	0.00159	0.00169	CcSEcCtD
Entecavir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00158	0.00169	CcSEcCtD
Entecavir—Nausea—Pamidronate—osteoporosis	0.00156	0.00167	CcSEcCtD
Entecavir—Dizziness—Conjugated Estrogens—osteoporosis	0.00153	0.00163	CcSEcCtD
Entecavir—Vomiting—Zoledronate—osteoporosis	0.00153	0.00163	CcSEcCtD
Entecavir—Rash—Zoledronate—osteoporosis	0.00151	0.00161	CcSEcCtD
Entecavir—Gastrointestinal pain—Estradiol—osteoporosis	0.00151	0.00161	CcSEcCtD
Entecavir—Dermatitis—Zoledronate—osteoporosis	0.00151	0.00161	CcSEcCtD
Entecavir—Headache—Zoledronate—osteoporosis	0.0015	0.0016	CcSEcCtD
Entecavir—Vomiting—Conjugated Estrogens—osteoporosis	0.00147	0.00157	CcSEcCtD
Entecavir—Body temperature increased—Estradiol—osteoporosis	0.00146	0.00156	CcSEcCtD
Entecavir—Abdominal pain—Estradiol—osteoporosis	0.00146	0.00156	CcSEcCtD
Entecavir—Rash—Conjugated Estrogens—osteoporosis	0.00146	0.00155	CcSEcCtD
Entecavir—Dermatitis—Conjugated Estrogens—osteoporosis	0.00146	0.00155	CcSEcCtD
Entecavir—Headache—Conjugated Estrogens—osteoporosis	0.00145	0.00154	CcSEcCtD
Entecavir—Nausea—Zoledronate—osteoporosis	0.00143	0.00152	CcSEcCtD
Entecavir—Nausea—Conjugated Estrogens—osteoporosis	0.00137	0.00146	CcSEcCtD
Entecavir—Asthenia—Estradiol—osteoporosis	0.00133	0.00142	CcSEcCtD
Entecavir—Diarrhoea—Estradiol—osteoporosis	0.00127	0.00135	CcSEcCtD
Entecavir—Dizziness—Estradiol—osteoporosis	0.00122	0.0013	CcSEcCtD
Entecavir—Vomiting—Estradiol—osteoporosis	0.00118	0.00125	CcSEcCtD
Entecavir—Rash—Estradiol—osteoporosis	0.00117	0.00124	CcSEcCtD
Entecavir—Dermatitis—Estradiol—osteoporosis	0.00117	0.00124	CcSEcCtD
Entecavir—Headache—Estradiol—osteoporosis	0.00116	0.00124	CcSEcCtD
Entecavir—Nausea—Estradiol—osteoporosis	0.0011	0.00117	CcSEcCtD
